All Cancer Microbiology articles – Page 13
-
NewsOral lipid nanoparticle drug can prevent development of colitis-associated cancer
An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University. The findings published in the journal Pharmaceutics report the ...
-
NewsISM hosting symposium on probiotics and microbiota supplements applications
The International Society of Microbiota has announced an upcoming symposium dedicated to clinicians on probiotics and microbiota supplements.
-
NewsResearchers tweak photosynthetic bacteria to combat tumours
Scientists succeed in enhancing the anticancer efficacies of purple photosynthetic bacteria by tagging them with bioactive molecules and polyethylene glycol derivatives.
-
NewsHigh-fat diets alter gut bacteria, boosting colorectal cancer risk in mice
Scientists have pinpointed specific microbes and bile acids that become more prevalent in the guts of mice fed high-fat diets.
-
NewsPurecap technique opens doors to more effective mRNA vaccines
Researchers have developed a method to produce highly active mRNA vaccines at high purity using a unique cap to easily separate the desired capped mRNA.
-
NewsNanoparticle may improve mRNA cancer vaccines
Tests in mice with melanoma and colon cancer show the tiny particle creates an ‘army’ of immune cells that carry vaccine’s instructions, say the researchers.
-
NewsCombining virus therapy with radiation to fight brain cancer works better than either treatment alone
Combining a cancer-targeting virus with radiation to treat brain cancer in mice was more effective than either therapy on its own, according to new research, providing hope for new treatments that combine immunotherapy with traditional surgery, chemotherapy or radiation.
-
NewsVirus aids breakthrough in glioblastoma treatment
Scientists have reported a breakthrough in glioblastoma treatment following a recent clinical trial that used a modified cold virus injected directly into the tumor.
-
NewsGut microbiome changes linked to precancerous colon polyps
A new study has linked certain types of gut bacteria to the development of precancerous colon polyps.
-
NewsEngineered virus with immunotherapy safe and improves cancer outcomes
A new study validates the safety of a combination approach using an engineered virus and immunotherapy to target an aggressive brain cancer, and offers promise to adapt treatment strategies.
-
NewsIntestinal bacteria influence the growth of fungi
The bacteria present in the intestine provide information about the quantities of fungi of the potentially disease-causing Candida genus - among them, surprisingly, are lactic acid bacteria that are known for their protective effect against fungal infections.
-
NewsCRISPR-based drug candidate targets the microbiome
Scientists have engineered the first published CRISPR-based candidate for a drug - a combination of phages - that targets E. coli directly and leaves the microbiome intact.
-
NewsTumour bacteria can trigger anticancer response
A novel approach to treating cancer uses bacteria that naturally reside within tumours to trigger a powerful anticancer immune response.
-
NewsAntibacterial treatment solves radiotherapy skin problem
A new study shows that a low-cost antibacterial regimen can prevent acute radiation dermatitis.
-
NewsGene scissors used successfully in the laboratory against HIV-related virus
Researchers have provided initial proof of concept for a potential therapeutic approach targeting HTLV-1, a retrovirus that triggers aggressive forms of leukemia or an incurable spinal cord disease that leads to paralysis.
-
NewsResearchers find regulatory mechanism that keeps cancer-causing bacteria in check
Researchers have discovered an important mechanism that may have profound implications for how we prevent colorectal cancer.
-
NewsEngineered E. coli delivers therapeutic nanobodies to the gut
A genetically modified beneficial strain of bacteria blocks intestinal inflammation in a preclinical model of inflammatory bowel disease and has the potential to treat intestinal-based diseases.
-
NewsProof of concept study uses bacteria to deliver radiation therapy to tumours
Researchers are using bacteria as an adapter to connect powerful radiation therapy to cancer cells.
-
NewsStudy finds diverse differences in microbes in breast tumours from women of different races
The breast tumours of Asian, black and white women have very different cellular, microbial and genomic features that could potentially be used to personalize care or predict disease progression, according to new research by investigators at the Johns Hopkins Kimmel Cancer Center. Source: National Cancer Institute Potential ...
-
NewsGut microbiome influences how lymphoma patients respond to CAR T therapy
Study finds antibiotic treatment and different types of microorganisms can impact chimeric antigen receptor T-cell therapy outcomes.